×
About 110,782 results

ALLMedicine™ Squamous Cell Carcinoma Center

Research & Reviews  54,315 results

Wnt/β-Catenin signaling pathway participates in the effect of miR-626 on oral squamous ...
https://doi.org/10.1111/jop.13216
Journal of Oral Pathology & Medicine : Official Publicati... Cui SH, Hu XD et. al.

Jun 14th, 2021 - The role of miR-626 in oral squamous cell carcinoma (OSCC) was investigated by targeting RASSF4. MiR-626 and RASSF4 expression was detected in normal oral mucosa or OSCC tissues and OSCC or normal cells. The methylation status of RASSF4 was analyz...

Prognostic Value of Tertiary Lymphoid Structures in Early Clinical Stage Oral Tongue Sq...
https://doi.org/10.1111/jop.13215
Journal of Oral Pathology & Medicine : Official Publicati... Wang C, Huang Z et. al.

Jun 14th, 2021 - Tertiary lymphoid structures have been observed in several solid tumors and suggested to be a favorable prognostic factor. However, the prognostic value of tertiary lymphoid structures for early clinical stage (cT1/2N0) oral tongue squamous cell c...

Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patient...
https://doi.org/10.1016/j.ygyno.2021.06.005
Gynecologic Oncology; Benito V, Lubrano A et. al.

Jun 13th, 2021 - To evaluate the clinical value of postreatment plasmatic levels of the squamous cell carcinoma antigen (SCC-Ag) as a survival independent prognostic factor in patients with LACC. Retrospective, multicenter study including LACC patients (FIGO 2009 ...

ASO Visual Abstract: Additional Treatment Following Noncurative Endoscopic Resection fo...
https://doi.org/10.1245/s10434-021-10260-2
Annals of Surgical Oncology; Kanie Y, Okamura A et. al.

Jun 13th, 2021 - ASO Visual Abstract: Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma-A Comparison of Outcomes Between Esophagectomy and Chemoradiotherapy.|2021|Kanie Y,Okamura A,Asari T,Maruyama S,Sakamoto K,|

see more →

Guidelines  137 results

ACR Appropriateness Criteria® Staging and Follow-up of Vulvar Cancer.
https://doi.org/10.1016/j.jacr.2021.02.016
Journal of the American College of Radiology : JACR; , Lakhman Y et. al.

May 7th, 2021 - Vulvar cancer is an uncommon gynecologic tumor and one of several human papillomavirus-associated malignancies. Squamous cell carcinoma is the most prevalent histologic subtype of vulvar cancer, accounting for the majority of cases. Imaging plays ...

Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ES...
https://doi.org/10.1016/j.annonc.2020.07.011
Annals of Oncology : Official Journal of the European Soc... Machiels JP, René Leemans C et. al.

Nov 26th, 2020 - Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.|2020|Machiels JP,René Leemans C,Golusinski W,Grau C,Licitra L,|diagnosis,epidemiol...

Immunotherapy and Beyond: Treatment Options and Potential Markers in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200227/full/

Jul 2nd, 2020 - Head and neck cancers account for approximately 4% of all cancers in the United States1 and are the eighth most common cancer affecting men in the United States.2 The diagnosis of recurrent or metastatic head and neck squamous cell carcinoma (R/M ...

Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline.
https://doi.org/10.1200/JCO.20.00866
Journal of Clinical Oncology : Official Journal of the Am... Shah MA, Kennedy EB et. al.

Jun 22nd, 2020 - To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with locally advanced esophageal cancer. ASCO convened an Expert Panel to conduct a systematic review of the more recently published litera...

FDA approves nivolumab for esophageal squamous cell carcinoma
https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-nivolumab-esophageal-squamous-cell-carcinoma
FDA

Jun 9th, 2020 - On June 10, 2020, the Food and Drug Administration approved nivolumab (OPDIVO, Bristol-Myers Squibb Co.) for patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) after prior fluoropyrimidine- and p...

see more →

Drugs  31 results see all →

Clinicaltrials.gov  55,315 results

Saliva Test to Detect HPV-Associated Throat Cancer
https://www.medscape.com/viewarticle/953180

Jun 15th, 2021 - A novel saliva test has been shown to detect HPV-associated oropharyngeal squamous cell carcinoma (OPSSC) with high accuracy in a small study. If the results are validated in subsequent studies, the test has the potential to be used as a screening...

Wnt/β-Catenin signaling pathway participates in the effect of miR-626 on oral squamous ...
https://doi.org/10.1111/jop.13216
Journal of Oral Pathology & Medicine : Official Publicati... Cui SH, Hu XD et. al.

Jun 14th, 2021 - The role of miR-626 in oral squamous cell carcinoma (OSCC) was investigated by targeting RASSF4. MiR-626 and RASSF4 expression was detected in normal oral mucosa or OSCC tissues and OSCC or normal cells. The methylation status of RASSF4 was analyz...

Prognostic Value of Tertiary Lymphoid Structures in Early Clinical Stage Oral Tongue Sq...
https://doi.org/10.1111/jop.13215
Journal of Oral Pathology & Medicine : Official Publicati... Wang C, Huang Z et. al.

Jun 14th, 2021 - Tertiary lymphoid structures have been observed in several solid tumors and suggested to be a favorable prognostic factor. However, the prognostic value of tertiary lymphoid structures for early clinical stage (cT1/2N0) oral tongue squamous cell c...

Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patient...
https://doi.org/10.1016/j.ygyno.2021.06.005
Gynecologic Oncology; Benito V, Lubrano A et. al.

Jun 13th, 2021 - To evaluate the clinical value of postreatment plasmatic levels of the squamous cell carcinoma antigen (SCC-Ag) as a survival independent prognostic factor in patients with LACC. Retrospective, multicenter study including LACC patients (FIGO 2009 ...

ASO Visual Abstract: Additional Treatment Following Noncurative Endoscopic Resection fo...
https://doi.org/10.1245/s10434-021-10260-2
Annals of Surgical Oncology; Kanie Y, Okamura A et. al.

Jun 13th, 2021 - ASO Visual Abstract: Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma-A Comparison of Outcomes Between Esophagectomy and Chemoradiotherapy.|2021|Kanie Y,Okamura A,Asari T,Maruyama S,Sakamoto K,|

see more →

News  953 results

Saliva Test to Detect HPV-Associated Throat Cancer
https://www.medscape.com/viewarticle/953180

Jun 15th, 2021 - A novel saliva test has been shown to detect HPV-associated oropharyngeal squamous cell carcinoma (OPSSC) with high accuracy in a small study. If the results are validated in subsequent studies, the test has the potential to be used as a screening...

Immunotherapy Likely New Standard in Advanced Esophageal Cancer
https://www.medscape.com/viewarticle/952393

Jun 2nd, 2021 - Nivolumab (Opdivo) plus chemotherapy and nivolumab plus ipilimumab (Yervoy) were superior to standard chemotherapy in improving overall survival in patients with advanced esophageal squamous cell carcinoma (ESCC), new results of a phase 3 trial sh...

Combined Imaging Methods Found to Enhance Detection of SCC
https://www.medscape.com/viewarticle/951575

May 19th, 2021 - Combined reflectance confocal microscopy–optical coherence tomography is a noninvasive tool that could prove useful in the detection of squamous cell carcinoma (SCC) and distinguishing SCC in-situ and actinic keratosis (AK) from invasive SCC, resu...

Fast Five Quiz: Squamous Cell Non-Small Cell Lung Cancer
https://reference.medscape.com/viewarticle/928233

May 4th, 2021 - Lung cancer continues to be the leading cause of cancer-related deaths worldwide. Non–small cell lung cancer (NSCLC), which accounts for 85% of all lung cancers, is divided histologically into adenocarcinoma, squamous cell carcinoma, and large cel...

Fast Five Quiz: Non–Small Cell Lung Cancer Management
https://reference.medscape.com/viewarticle/923235

Feb 2nd, 2021 - Non–small cell lung cancer (NSCLC) accounts for the vast majority of all lung cancers and is a leading cause of death worldwide. Histologically, NSCLC is characterized as adenocarcinoma, squamous cell carcinoma, or large cell carcinoma. A complete...

see more →

Patient Education  31 results see all →